XML 134 R120.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Parent Only Financial Information Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Cash Provided by (Used in) Operating Activities                      
Net income $ 9,770 $ 9,941 $ 8,337 $ 8,979 $ 10,156 $ 10,826 $ 11,204 $ 8,672 $ 37,027 $ 40,858 $ 35,755
Share-based compensation                 2,977 2,584 2,513
Excess tax benefit from share-based compensation                 194 264 48
Net cash provided by operating activities                 52,292 38,645 35,992
Net Cash Provided by (Used in) Investing Activities                      
Proceeds from redemption of Trust II stock                 0 315 0
Payments of Distributions to Affiliates                 (15,000) 0 0
Net cash used in investing activities                 (506,849) (245,267) (111,012)
Net Cash Provided by (Used in) Financing Activities                      
Proceeds from issuance of subordinated notes payable                 15,000 20,000 0
Repayment of subordinated notes payable                 0 (9,090) 0
Repayment of junior subordinated debt                 0 (10,076) 0
Proceeds from Issuance of Preferred Stock and Preference Stock                 0 11,992 0
Purchase of treasury stock                 (2,971) (6,126) (5,478)
Preferred stock dividends paid                 (875) (683) 0
Cash dividends paid                 (7,578) (6,688) (6,166)
Proceeds from purchases of Employee Stock Purchase Plan shares                 128 134 160
Net cash provided by financing activities                 491,385 252,194 75,221
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect                 36,828 45,572 201
Cash and cash equivalents at the beginning of the period       102,682         102,682    
Cash and cash equivalents at the end of the period 139,510       102,682       139,510 102,682  
Parent company                      
Net Cash Provided by (Used in) Operating Activities                      
Net income                 37,027 40,858 35,755
Equity in undistributed earnings of consolidated subsidiaries                 (41,226) (43,536) (40,107)
Share-based compensation                 2,977 2,584 2,513
Excess tax benefit from share-based compensation                 (91) (91) (27)
Net (decrease) increase in other liabilities                 (1,854) 2,592 (2,090)
Other, net                 1,207 (538) 3,413
Net cash provided by operating activities                 (1,960) 1,869 (543)
Net Cash Provided by (Used in) Investing Activities                      
Dividends received from subsidiaries                 12,100 2,008 8,534
Proceeds from redemption of Trust II stock                 0 315 0
Net cash used in investing activities                 (2,900) 2,323 8,534
Net Cash Provided by (Used in) Financing Activities                      
Proceeds from Issuance of Long-term Debt                 54 (357) 55
Proceeds from issuance of subordinated notes payable                 15,000 20,000 0
Repayment of subordinated notes payable                 0 (9,090) 0
Repayment of junior subordinated debt                 0 (10,076) 0
Proceeds from Issuance of Preferred Stock and Preference Stock                 0 11,992 0
Proceeds from (Repayments of) Short-term Debt                 0 (500) 500
Purchase of treasury stock                 (2,971) (6,126) (5,477)
Preferred stock dividends paid                 (875) (683) 0
Cash dividends paid                 (7,578) (6,688) (6,166)
Net cash provided by financing activities                 3,758 (1,394) (10,928)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect                 (1,102) 2,798 (2,937)
Cash and cash equivalents at the beginning of the period       $ 3,129       $ 331 3,129 331 3,268
Cash and cash equivalents at the end of the period $ 2,027       $ 3,129       $ 2,027 $ 3,129 $ 331